Vindesine
![]() | |
![]() | |
Systematic (IUPAC) name | |
---|---|
methyl (5S,7S,9S)- 9-[(2β,3β,4β,5α,12β,19α)- 3-(aminocarbonyl)- 3,4-dihydroxy- 16-methoxy- 1-methyl- 6,7-didehydroaspidospermidin- 15-yl]- 5-ethyl- 5-hydroxy- 1,4,5,6,7,8,9,10-octahydro- 2H- 3,7-methanoazacycloundecino[5,4-b]indole- 9-carboxylate | |
Clinical data | |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Pregnancy category |
|
Routes of administration | Intravenous |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 65-75% |
Metabolism | Hepatic (CYP3A4-mediated) |
Biological half-life | 24 hours |
Excretion | Biliary and renal |
Identifiers | |
CAS Number |
59917-39-4 ![]() |
ATC code | L01CA03 (WHO) |
PubChem | CID 40839 |
DrugBank |
DB00309 ![]() |
ChemSpider |
37302 ![]() |
UNII |
RSA8KO39WH ![]() |
KEGG |
D01769 ![]() |
ChEBI |
CHEBI:36373 ![]() |
ChEMBL |
CHEMBL219146 ![]() |
Chemical data | |
Formula | C43H55N5O7 |
Molar mass | 753.926 g/mol |
| |
| |
(verify) |
Vindesine is an anti-mitotic vinca alkaloid used in chemotherapy. It is used to treat many different types of cancer, including leukaemia, lymphoma, melanoma, breast cancer, and lung cancer.[1]
References
|
This article is issued from Wikipedia - version of the Sunday, April 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.